查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1576935

经导管主动脉瓣置换 (TAVR)/拘留 (TAVI):市场洞察·竞争环境·市场预测 (～2030年)

Transcatheter Aortic Valve Replacement/Implantation - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

经导管主动脉瓣置换(TAVR) 设备市场规模预计将从2023 年的28 亿美元成长到2030 年的66 亿美元，2024 年至2030 年的预测期内复合年增长率为15.41%。预计将增长到 。

主动脉瓣狭窄、主动脉瓣逆流和二尖瓣逆流等慢性疾病病例的增加、包括产品发布在内的产品开发活动的增加以及老年人口的增加推动了 TAVR 设备市场的成长。很大程度是由于以下因素：

TAVR 设备市场动态：

根据美国国立卫生研究院2022 年的数据，主动脉瓣狭窄是已开发国家最常见的瓣膜疾病，平均影响全球900 万人，据报道，随着人口老化和人口老化，其发病率不断增加。主动脉瓣关闭不全与舒张期高血压而非收缩期高血压有关，且在已开发国家也呈现增加趋势。二尖瓣关闭不全影响全世界 2,400 万人，各国之间有很大差异。

TAVR对于瓣膜性心臟病，尤其是主动脉瓣狭窄的治疗极为重要。由于这些疾病通常与老化和相关健康问题有关，TAVR 为无法耐受传统手术的高风险患者提供了微创解决方案。透过实现有效的瓣膜置换术和更短的恢復时间，TAVR 满足了在人口老化和动脉粥状硬化发病率上升的情况下对主动脉和相关瓣膜病变进行先进治疗的需求。

北美预计将主导整个经导管主动脉瓣置换装置市场：

在所有地区中，北美预计在经导管主动脉瓣置换设备市场中占据最大的收入占有率。这是由于主动脉瓣狭窄负担日益加重、监管支持、及时和完善的医疗服务和基础设施、主要参与者的存在以及2024 年至2030 年北美经导管主动脉瓣置换设备市场的成长。其他因素造成的预计将成为显着的推动因素。

本报告提供全球经导管主动脉瓣置换 (TAVR)/树丛 (TAVI) 的市场调查，彙整市场概要，市场影响因素及市场机会分析，法律制度，市场规模的转变·预测，各种区分·地区/各主要国家的详细分析，竞争情形，主要企业简介等资讯。

目录

第1章 经导管主动脉瓣置换 (TAVR) 设备市场:简介

第2章 经导管主动脉瓣置换 (TAVR) 设备市场:摘要整理

第3章 竞争情形

第4章 法规分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第5章 经导管主动脉瓣置换 (TAVR) 设备市场:主要要素分析

  • 推动市场要素
    • 慢性疾病增加
    • 扩大全球产品开发活动
    • 人口老化加剧
  • 阻碍市场要素·课题
    • 出血、血肿及血管损伤等副作用
    • 可供选择的替代方案
  • 市场机会
    • 开发改良且耐用的生物瓣膜
    • 整合精准相关的人工智慧和机器人辅助

第6章 经导管主动脉瓣置换 (TAVR) 设备市场:波特的五力分析

第7章 经导管主动脉瓣置换 (TAVR) 设备市场:市场评估

  • 各材料
    • 阀架材料
    • 瓣尖材料
  • 各治疗
    • 经大腿方法
    • 经心尖方法
    • 经主动脉方法
  • 各用途
    • 主动脉瓣狭窄症
    • 主动脉瓣逆流症
    • 其他
  • 各终端用户
    • 医院
    • 门诊病人手术中心
  • 各地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他地区

第8章 经导管主动脉瓣置换 (TAVR) 设备市场:企业·产品简介

  • Medtronic
  • Edwards Lifesciences Corporation
  • Boston Scientific Corporation
  • Meril Life Sciences
  • Abbott
  • JenaValve Technology, Inc.
  • Bracco SpA
  • CryoLife, Inc.
  • Braile Biomedica
  • Venus Medtech
  • Transcatheter Technologies Gmbh
  • Thubrikar Aortic Valve
  • Blue Sail Medical Co. Ltd.
  • JC Medical Inc.
  • Cook
  • Sysmetis SA
  • SMT Pvt Ltd.
  • LivaNova
  • Peijia Medical
  • P+F Products + Features GmbH

第9章 KOL的见解

第10章 计划方法

第11章 关于DelveInsight

第12章 免责声明·咨询方式

Product Code: DIMDCL0209

Transcatheter Aortic Valve Replacement (TAVR) Devices Market by Material [Valve Frame Material (Nitinol, Stainless Steel, Cobalt Chromium, and Others), and Valve Leaflet Material (Porcine, Bovine and, Others)], Procedure (Transfemoral, Transapical and Transaortic Approach), Application (Aortic Stenosis, Aortic Regurgitation, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2030 owing to the increasing instances of chronic disorders and increasing product developmental activities worldwide

The transcatheter aortic valve replacement devices market was valued at USD 2.80 billion in 2023, growing at a CAGR of 15.41% during the forecast period from 2024 to 2030 to reach USD 6.60 billion by 2030. The transcatheter aortic valve replacement devices market is experiencing significant growth due to the increasing instances of chronic disorders such as aortic valve stenotic disease, aortic regurgitation, and mitral regurgitation, increasing product developmental activities including product launches, rising geriatric population, and others that are acting as major factors driving the substantial demand for transcatheter aortic valve replacement devices market from 2024 to 2030.

Transcatheter Aortic Valve Replacement Devices Market Dynamics:

The National Institute of Health (2022), stated that aortic valve stenotic disease was the most commonly occurring valvar pathology in developed nations, affecting 9 million people worldwide on an average, and its prevalence was increasing with aging population and the rise of atherosclerosis. Aortic regurgitation was associated with diastolic, but not systolic, hypertension, and it similarly saw an increase in developed countries. Mitral regurgitation affected 24 million people globally, with significant variability between and among nations.

TAVR devices are crucial in treating prevalent valvar diseases, especially aortic stenosis. As these conditions are often linked with aging and related health issues, TAVR offers a minimally invasive solution for high-risk patients who may not tolerate traditional surgery. By enabling effective valve replacement with shorter recovery times, TAVR addresses the growing need for accessible, advanced treatments for aortic and related valve pathologies in the face of an aging population and rising atherosclerosis rates.

Various product developmental strategies by the market key players such as introduction of new and innovative products are likely to push forward the revenue shares for the same. For example, in February 2024, Edwards Lifesciences Corporation announced launch of the Sapien 3 Ultra Resilia valve in Europe.

Hence, the interplay of all the above-mentioned factors is expected to drive the transcatheter aortic valve replacement devices market during the given forecast period from 2024 to 2030.

However, side effects such as bleeding, hematoma, or vascular injury, availability of alternative options, among others may restrict the market growth for the transcatheter aortic valve replacement devices market.

Transcatheter Aortic Valve Replacement Devices Market Segment Analysis:

Transcatheter Aortic Valve Replacement Devices Market by Material [Valve Frame Material (Nitinol, Stainless Steel, Cobalt Chromium, and Others), and Valve Leaflet Material (Porcine, Bovine and, Others)], Procedure (Transfemoral, Transapical and Transaortic Approach), Application (Aortic Stenosis, Aortic Regurgitation, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the procedure segment of the transcatheter aortic valve replacement devices market, the transfemoral category is expected to have a significant revenue share in the year 2023. The rapid growth of the transfemoral procedure for transcatheter aortic valve replacement is due to its widely utilized approach that offers several distinctive features and benefits, making it a preferred option for many patients with aortic valve stenosis.

One of the primary features of this technique is its minimally invasive nature, as it involves accessing the aorta through the femoral artery in the groin, which typically results in a smaller incision and less surgical trauma. This approach leads to significant benefits, including a shorter recovery time.

Additionally, advancements in imaging and device technology have improved the precision of valve placement during the procedure, leading to better overall results. The transfemoral approach is also beneficial for patients with favorable femoral artery anatomy, as it allows for straightforward access without the need for complex surgical interventions.

Therefore, owing to the above-mentioned factors, the demand for the transfemoral category upsurges, thereby the category is expected to witness considerable growth eventually contributing to the overall growth of the transcatheter aortic valve replacement devices market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall transcatheter aortic valve replacement devices market:

Among all the regions, North America is estimated to hold a significant revenue share in the transcatheter aortic valve replacement devices market. This is driven by the growing burden of aortic stenosis, regulatory support, prompt and well-established healthcare services and infrastructure, presence of key players, and other that are anticipated to significantly propel market growth for transcatheter aortic valve replacement devices in North America from 2024 to 2030.

According to data from the American Heart Association (2024), it stated that more that 20% of older Americans currently suffers from aortic stenosis. Same source further stated that it is more common in people of age 60 and above. Transcatheter aortic valve replacement devices are widely used to treat older individuals suffering from aortic stenosis. These offers minimally invasive alternative to traditional open-heart surgery. By replacing the narrowed aortic valve through a catheter-based procedure, this improves blood flow and heart function, helping these patients regain quality of life with reduced recovery time and fewer complications.

Various product developmental strategies such as clearances by the regulatory authorities in the region play a major role in pushing forward the revenue shares of transcatheter aortic valve replacement devices in the region. For example, in September 2021, Abbott announced that Food and Drug Administration approved the company's Portico(TM) with FlexNav(TM) transcatheter aortic valve replacement (TAVR) system to treat people with symptomatic, severe aortic stenosis who are at high or extreme risk for open-heart surgery.

The prompt and well-established healthcare services and infrastructure further contribute to the growth of the regional transcatheter aortic valve replacement devices market. The presence of key players such as Medtronic, Boston Scientific Corporation, and Abbott with their strong distribution networks ensure widespread availability and accessibility of these devices across the region increasing their revenue shares in the market, and supportive reimbursement programs providing immense growth opportunities for the same.

Therefore, the interplay of all the factors mentioned above would provide a conducive growth environment for the North America region in the transcatheter aortic valve replacement devices market during the forecast period from 2024 to 2030.

Transcatheter Aortic Valve Replacement Devices Market key players:

Some of the key market players operating in the transcatheter aortic valve replacement devices market include Medtronic, Edwards Lifesciences Corporation, Boston Scientific Corporation, Meril Life Sciences, Abbott, JenaValve Technology, Inc., Bracco SpA, CryoLife, Inc., Braile Biomedica, Venus Medtech, Transcatheter Technologies Gmbh, Thubrikar Aortic Valve, Blue Sail Medical Co. Ltd., JC Medical Inc., Cook, Sysmetis SA, SMT Pvt Ltd., LivaNova, Peijia Medical, P+F Products + Features GmbH, and others.

Recent Developmental Activities in the Transcatheter Aortic Valve Replacement Devices Market:

  • In August 2024, Boston Scientific Corporation announced that it secured CE mark for the ACURATE Prime(TM) Aortic Valve System, the newest transcatheter aortic valve replacement (TAVR) technology.
  • In August 2021, Medtronic, announced the U.S. Food and Drug Administration approval of its newest-generation, self-expanding transcatheter aortic valve replacement (TAVR) system, the Evolut(TM) FX TAVR system.
  • In May 2021, Abbott announced that it received CE Mark for its latest-generation transcatheter aortic valve implantation (TAVI) system, Navitor(TM), making the minimally invasive device available for people in Europe with severe aortic stenosis who are at high or extreme surgical risk.

Key takeaways from the Transcatheter Aortic Valve Replacement Devices market report study

  • Market size analysis for current transcatheter aortic valve replacement devices market size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the transcatheter aortic valve replacement devices market
  • Various opportunities available for the other competitors in the transcatheter aortic valve replacement devices market space
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current transcatheter aortic valve replacement devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for transcatheter aortic valve replacement devices market growth in the coming future?

Target audience who can be benefited from this Transcatheter Aortic Valve Replacement Devices market report study

  • Transcatheter aortic valve replacement devices device providers
  • Research organizations and consulting companies
  • Transcatheter aortic valve replacement devices related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in transcatheter aortic valve replacement devices
  • Various end-users who want to know more about the transcatheter aortic valve replacement devices market and the latest developments in the transcatheter aortic valve replacement devices market

Frequently Asked Questions for the Transcatheter Aortic Valve Replacement Devices Market:

1. What are Transcatheter Aortic Valve Replacement Devices?

  • The transcatheter aortic valve replacement is a procedure wherein the diseased valve is replaced by an artificial, man-made valve. There are a number of man-made transcatheter aortic valves that are used while performing TAVR procedures. These include SAPIEN 3, SAPIEN 3 Ultra, Evolut PRO+, and LOTUS Edge.

2. What is the market for Transcatheter Aortic Valve Replacement Devices?

  • The transcatheter aortic valve replacement devices market was valued at USD 2.80 billion in 2023, growing at a CAGR of 15.41% during the forecast period from 2024 to 2030 to reach USD 6.60 billion by 2030.

3. What are the drivers for the Transcatheter Aortic Valve Replacement Devices market?

  • The transcatheter aortic valve replacement devices market is experiencing significant growth due to the increasing instances of chronic disorders such as aortic valve stenotic disease, aortic regurgitation, and mitral regurgitation, increasing product developmental activities including product launches, rising geriatric population, and others that are acting as major factors driving the substantial demand for transcatheter aortic valve replacement devices market from 2024 to 2030.

4. Who are the key players operating in the Transcatheter Aortic Valve Replacement Devices market?

  • Some of the major market key players operating in the transcatheter aortic valve replacement devices market include Medtronic, Edwards Lifesciences Corporation, Boston Scientific Corporation, Meril Life Sciences, Abbott, JenaValve Technology, Inc., Bracco SpA, CryoLife, Inc., Braile Biomedica, Venus Medtech, Transcatheter Technologies Gmbh, Thubrikar Aortic Valve, Blue Sail Medical Co. Ltd., JC Medical Inc., Cook, Sysmetis SA, SMT Pvt Ltd., LivaNova, Peijia Medical, P+F Products + Features GmbH, and others.

5. Which region has the highest share in the Transcatheter Aortic Valve Replacement Devices market?

  • Among all the regions, North America is estimated to hold a significant revenue share in the transcatheter aortic valve replacement devices market. This is driven by the growing burden of aortic stenosis, regulatory support, prompt and well-established healthcare services and infrastructure, presence of key players, and other that are anticipated to significantly propel market growth for transcatheter aortic valve replacement devices in North America from 2024 to 2030.

Table of Contents

1. Transcatheter Aortic Valve Replacement Devices Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Transcatheter Aortic Valve Replacement Devices Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Transcatheter Aortic Valve Replacement Devices Market Key Factors Analysis

  • 5.1. Transcatheter Aortic Valve Replacement Devices Market Drivers
    • 5.1.1. Increasing instances of chronic disorders
    • 5.1.2. Increasing product developmental activities worldwide
    • 5.1.3. Rising geriatric population
  • 5.2. Transcatheter Aortic Valve Replacement Devices Market Restraints and Challenges
    • 5.2.1. Side effects such as bleeding, hematoma, or vascular injury
    • 5.2.2. Availability of alternative options
  • 5.3. Transcatheter Aortic Valve Replacement Devices Market Opportunities
    • 5.3.1. Development improved, durable and bio-prosthetic valves
    • 5.3.2. Integration of artificial intelligence (AI) and robotic assistance associated with precision

6. Transcatheter Aortic Valve Replacement Devices Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Transcatheter Aortic Valve Replacement Devices Market Assessment

  • 7.1. By Material
    • 7.1.1. Valve Frame material
      • 7.1.1.1. Nitinol
      • 7.1.1.2. Stainless Steel
      • 7.1.1.3. Cobalt-chromium
      • 7.1.1.4. Others
    • 7.1.2. Valve Leaflet Material
      • 7.1.2.1. Porcine
      • 7.1.2.2. Bovine
      • 7.1.2.3. Others
  • 7.2. By Procedure
    • 7.2.1. Transfemoral Approach
    • 7.2.2. Transapical Approach
    • 7.2.3. Transaortic Approach
  • 7.3. By Application
    • 7.3.1. Aortic Stenosis
    • 7.3.2. Aortic Regurgitation
    • 7.3.3. Others
  • 7.4. By End-User
    • 7.4.1. Hospitals
    • 7.4.2. Ambulatory Surgical Centers
    • 7.4.3. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. United States Transcatheter Aortic Valve Replacement Devices Market Size in USD million (2021-2030)
      • 7.5.1.2. Canada Transcatheter Aortic Valve Replacement Devices Market Size in USD million (2021-2030)
      • 7.5.1.3. Mexico Transcatheter Aortic Valve Replacement Devices Market Size in USD million (2021-2030)
    • 7.5.2. Europe
      • 7.5.2.1. France Transcatheter Aortic Valve Replacement Devices Market Size in USD million (2021-2030)
      • 7.5.2.2. Germany Transcatheter Aortic Valve Replacement Devices Market Size in USD million (2021-2030)
      • 7.5.2.3. United Kingdom Transcatheter Aortic Valve Replacement Devices Market Size in USD million (2021-2030)
      • 7.5.2.4. Italy Transcatheter Aortic Valve Replacement Devices market size in USD million (2021-2030)
      • 7.5.2.5. Spain Transcatheter Aortic Valve Replacement Devices Market Size in USD million (2021-2030)
      • 7.5.2.6. Rest of Europe Transcatheter Aortic Valve Replacement Devices Market Size in USD million (2021-2030)
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. China Transcatheter Aortic Valve Replacement Devices Market Size in USD million (2021-2030)
      • 7.5.3.2. Japan Transcatheter Aortic Valve Replacement Devices Market Size in USD million (2021-2030)
      • 7.5.3.3. India Transcatheter Aortic Valve Replacement Devices Market Size in USD million (2021-2030)
      • 7.5.3.4. Australia Transcatheter Aortic Valve Replacement Devices Market Size in USD million (2021-2030)
      • 7.5.3.5. South Korea Transcatheter Aortic Valve Replacement Devices Market Size in USD million (2021-2030)
      • 7.5.3.6. Rest of Asia-Pacific Transcatheter Aortic Valve Replacement Devices Market Size in USD million (2021-2030)
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. Middle East Transcatheter Aortic Valve Replacement Devices Market Size in USD million (2021-2030)
      • 7.5.4.2. Africa Transcatheter Aortic Valve Replacement Devices Market Size in USD million (2021-2030)
      • 7.5.4.3. South America Transcatheter Aortic Valve Replacement Devices Market Size in USD million (2021-2030)

8. Transcatheter Aortic Valve Replacement Devices Market Company and Product Profiles

  • 8.1. Medtronic
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Edwards Lifesciences Corporation
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Boston Scientific Corporation
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Meril Life Sciences
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Abbott
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. JenaValve Technology, Inc.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Bracco SpA
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. CryoLife, Inc.
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Braile Biomedica
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Venus Medtech
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Transcatheter Technologies Gmbh
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Thubrikar Aortic Valve
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Blue Sail Medical Co. Ltd.
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. JC Medical Inc.
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Cook
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Sysmetis SA
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. SMT Pvt Ltd.
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. LivaNova
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Peijia Medical
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. P+F Products + Features GmbH
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Transcatheter Aortic Valve Replacement Devices Market in Global (2021-2030)
  • Table 3: Transcatheter Aortic Valve Replacement Devices Market in Global by Material (2021-2030)
  • Table 4: Transcatheter Aortic Valve Replacement Devices Market in Global by Procedure (2021-2030)
  • Table 5: Transcatheter Aortic Valve Replacement Devices Market in Global by Application (2021-2030)
  • Table 6: Transcatheter Aortic Valve Replacement Devices Market in Global by End-User (2021-2030)
  • Table 7: Transcatheter Aortic Valve Replacement Devices Market in Global by Geography (2021-2030)
  • Table 8: Transcatheter Aortic Valve Replacement Devices Market in North America (2021-2030)
  • Table 9: Transcatheter Aortic Valve Replacement Devices Market in the United States (2021-2030)
  • Table 10: Transcatheter Aortic Valve Replacement Devices Market in Canada (2021-2030)
  • Table 11: Transcatheter Aortic Valve Replacement Devices Market in Mexico (2021-2030)
  • Table 12: Transcatheter Aortic Valve Replacement Devices Market in Europe (2021-2030)
  • Table 13: Transcatheter Aortic Valve Replacement Devices Market in France (2021-2030)
  • Table 14: Transcatheter Aortic Valve Replacement Devices Market in Germany (2021-2030)
  • Table 15: Transcatheter Aortic Valve Replacement Devices Market in United Kingdom (2021-2030)
  • Table 16: Transcatheter Aortic Valve Replacement Devices Market in Italy (2021-2030)
  • Table 17: Transcatheter Aortic Valve Replacement Devices Market in Spain (2021-2030)
  • Table 18: Transcatheter Aortic Valve Replacement Devices Market in the Rest of Europe (2021-2030)
  • Table 19: Transcatheter Aortic Valve Replacement Devices Market in Asia-Pacific (2021-2030)
  • Table 20: Transcatheter Aortic Valve Replacement Devices Market in China (2021-2030)
  • Table 21: Transcatheter Aortic Valve Replacement Devices Market in Japan (2021-2030)
  • Table 22: Transcatheter Aortic Valve Replacement Devices Market in India (2021-2030)
  • Table 23: Transcatheter Aortic Valve Replacement Devices Market in Australia (2021-2030)
  • Table 24: Transcatheter Aortic Valve Replacement Devices Market in South Korea (2021-2030)
  • Table 25: Transcatheter Aortic Valve Replacement Devices Market in Rest of Asia-Pacific (2021-2030)
  • Table 26: Transcatheter Aortic Valve Replacement Devices Market in the Rest of the World (2021-2030)
  • Table 27: Transcatheter Aortic Valve Replacement Devices Market in the Middle East (2021-2030)
  • Table 28: Transcatheter Aortic Valve Replacement Devices Market in Africa (2021-2030)
  • Table 29: Transcatheter Aortic Valve Replacement Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Transcatheter Aortic Valve Replacement Devices Market in Global (2021-2030)
  • Figure 3: Transcatheter Aortic Valve Replacement Devices Market in Global by Material (2021-2030)
  • Figure 4: Transcatheter Aortic Valve Replacement Devices Market in Global by Procedure (2021-2030)
  • Figure 5: Transcatheter Aortic Valve Replacement Devices Market in Global by Application (2021-2030)
  • Figure 6: Transcatheter Aortic Valve Replacement Devices Market in Global by End-User (2021-2030)
  • Figure 7: Transcatheter Aortic Valve Replacement Devices Market in Global by Geography (2021-2030)
  • Figure 8: Transcatheter Aortic Valve Replacement Devices Market in North America (2021-2030)
  • Figure 9: Transcatheter Aortic Valve Replacement Devices Market in the United States (2021-2030)
  • Figure 10: Transcatheter Aortic Valve Replacement Devices Market in Canada (2021-2030)
  • Figure 11: Transcatheter Aortic Valve Replacement Devices Market in Mexico (2021-2030)
  • Figure 12: Transcatheter Aortic Valve Replacement Devices Market in Europe (2021-2030)
  • Figure 13: Transcatheter Aortic Valve Replacement Devices Market in France (2021-2030)
  • Figure 14: Transcatheter Aortic Valve Replacement Devices Market in Germany (2021-2030)
  • Figure 15: Transcatheter Aortic Valve Replacement Devices Market in United Kingdom (2021-2030)
  • Figure 16: Transcatheter Aortic Valve Replacement Devices Market in Italy (2021-2030)
  • Figure 17: Transcatheter Aortic Valve Replacement Devices Market in Spain (2021-2030)
  • Figure 18: Transcatheter Aortic Valve Replacement Devices Market in the Rest of Europe (2021-2030)
  • Figure 19: Transcatheter Aortic Valve Replacement Devices Market in Asia-Pacific (2021-2030)
  • Figure 20: Transcatheter Aortic Valve Replacement Devices Market in China (2021-2030)
  • Figure 21: Transcatheter Aortic Valve Replacement Devices Market in Japan (2021-2030)
  • Figure 22: Transcatheter Aortic Valve Replacement Devices Market in India (2021-2030)
  • Figure 23: Transcatheter Aortic Valve Replacement Devices Market in Australia (2021-2030)
  • Figure 24: Transcatheter Aortic Valve Replacement Devices Market in South Korea (2021-2030)
  • Figure 25: Transcatheter Aortic Valve Replacement Devices Market in Rest of Asia-Pacific (2021-2030)
  • Figure 26: Transcatheter Aortic Valve Replacement Devices Market in the Rest of the World (2021-2030)
  • Figure 27: Transcatheter Aortic Valve Replacement Devices Market in the Middle East (2021-2030)
  • Figure 28: Transcatheter Aortic Valve Replacement Devices Market in Africa (2021-2030)
  • Figure 29: Transcatheter Aortic Valve Replacement Devices Market in South America (2021-2030)
  • Figure 30: Market Drivers
  • Figure 31: Market Barriers
  • Figure 32: Marker Opportunities
  • Figure 33: PORTER'S Five Force Analysis